Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Woodcock

Showing results (11-20 of 2,227) with videos related to

Pageof 223
Sort By:
Clinical Pharmacology and Therapeutics|September 14, 2007
Molecular medicine: how, what, and when?J Woodcock
Biomarkers in Medicine|May 19, 2010
Interview with Janet Woodcock: progress on the FDA's critical path initiativeJanet Woodcock
Frontiers in Artificial Intelligence|September 12, 2022
Artificial intelligence at work: The problem of managerial control from call centers to transport platformsJamie Woodcock
Clinical Pharmacology and Therapeutics|February 21, 2012
Evidence vs. access: can twenty-first-century drug regulation refine the tradeoffs?J Woodcock
Work (Reading, Mass.)|February 10, 2012
New insights, new challenges; person centred transport designAndree Woodcock
Addiction (Abingdon, England)|October 1, 1995
The 1994 annual lecture of the Society for the Study of Addiction. Commissions (Royal and other) on drug misuse: who needs them?J Woodcock
The British Journal of Surgery|June 11, 1999
Vascular surgical society of great britain and ireland: provision of an emergency vascular service: a three-hospital modelWoodcock, Hulton
Thorax|September 29, 2012
The president speaks: prevention is best: lessons from protecting the ozone layerAshley Woodcock
Clinical Pharmacology and Therapeutics|January 30, 2007
The prospects for "personalized medicine" in drug development and drug therapyJ Woodcock
Clinical Pharmacology and Therapeutics|August 22, 2013
The PCAST report on pharmaceutical innovation: implications for the FDAJ Woodcock
Pageof 223

Showing results (11-20 of 2,227) with videos related to

Sort By:
Pageof 223
Clinical Pharmacology and Therapeutics|September 14, 2007
Molecular medicine: how, what, and when?J Woodcock
Biomarkers in Medicine|May 19, 2010
Interview with Janet Woodcock: progress on the FDA's critical path initiativeJanet Woodcock
Frontiers in Artificial Intelligence|September 12, 2022
Artificial intelligence at work: The problem of managerial control from call centers to transport platformsJamie Woodcock
Clinical Pharmacology and Therapeutics|February 21, 2012
Evidence vs. access: can twenty-first-century drug regulation refine the tradeoffs?J Woodcock
Work (Reading, Mass.)|February 10, 2012
New insights, new challenges; person centred transport designAndree Woodcock
Addiction (Abingdon, England)|October 1, 1995
The 1994 annual lecture of the Society for the Study of Addiction. Commissions (Royal and other) on drug misuse: who needs them?J Woodcock
The British Journal of Surgery|June 11, 1999
Vascular surgical society of great britain and ireland: provision of an emergency vascular service: a three-hospital modelWoodcock, Hulton
Thorax|September 29, 2012
The president speaks: prevention is best: lessons from protecting the ozone layerAshley Woodcock
Clinical Pharmacology and Therapeutics|January 30, 2007
The prospects for "personalized medicine" in drug development and drug therapyJ Woodcock
Clinical Pharmacology and Therapeutics|August 22, 2013
The PCAST report on pharmaceutical innovation: implications for the FDAJ Woodcock
Pageof 223